Updated 2026-08-31 · NCT05819853See eligibility →
Sponsor
Clinical trials sponsored by University of Colorado, Denver
Active studies whose public registry record names University of Colorado, Denver as lead sponsor.
36active studies
18recruiting now
1countries represented
64largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowNot applicable
Effects of GLP-1 RAs on Human Lactation Outcomes
Updated 2026-07-22 · NCT07720414See eligibility →
Recruiting nowPhase 2, Phase 3
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Updated 2026-07-21 · NCT06975111See eligibility →
Recruiting nowPhase 2
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
Updated 2026-07-21 · NCT06686537See eligibility →
Updated 2026-07-15 · NCT06575738See eligibility →
Recruiting nowNot applicable
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
Updated 2026-05-15 · NCT06129110See eligibility →
Recruiting nowNot applicable
Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
Updated 2026-03-23 · NCT04791371See eligibility →
Recruiting nowNot applicable
Snacking Effects on the Brain Response to Foods and Satiety During Dieting
Updated 2026-03-23 · NCT07428187See eligibility →
Recruiting nowPhase 3
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
Updated 2026-03-04 · NCT05819138See eligibility →
Recruiting nowNot applicable
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
Updated 2026-02-12 · NCT05107908See eligibility →
Updated 2025-06-10 · NCT03762395See eligibility →
Recruiting nowPhase 2
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
Updated 2025-06-10 · NCT03885245See eligibility →
Recruiting nowPhase 2
Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
Updated 2025-05-06 · NCT06582875See eligibility →
Recruiting nowNot applicable
Thermogenenic Responses to Fasting and Overfeeding in Women
Updated 2025-04-30 · NCT06610162See eligibility →
Recruiting nowPhase 1
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
Updated 2024-11-27 · NCT06414096See eligibility →
Recruiting nowNot applicable
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
Updated 2024-05-14 · NCT06116435See eligibility →
Recruiting nowPhase 4
Bioenergetic Effects of Aging and Menopause (BEAM)
Updated 2023-12-18 · NCT04043520See eligibility →
Recruiting nowNot applicable
Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
Updated 2023-02-02 · NCT03215836See eligibility →
Opening soonPhase 3
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
Updated 2026-07-02 · NCT07021937See eligibility →
Opening soonNot applicable
Improving Sleep Health and Circadian Timing to Support Cardiometabolic Health in Adolescents
Updated 2026-06-01 · NCT07618117See eligibility →
Opening soonNot applicable
A 12-week Field Trial of the Movámonos Physical Activity Support Program
Updated 2026-05-01 · NCT07561996See eligibility →
Opening soonNot applicable
Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.
Updated 2025-03-04 · NCT06856928See eligibility →
Invitation onlyNot applicable
Linking Temporal Patterns of Modifiable Behaviors to Weight Loss Outcomes
Updated 2025-12-19 · NCT03840733See eligibility →
Invitation onlyNot applicable
Family Matters Intervention
Updated 2025-09-22 · NCT02669797See eligibility →
Invitation onlyNot applicable
PATHWEIGH: Pragmatic Weight Management in Primary Care
Updated 2025-05-30 · NCT04678752See eligibility →
Active, not recruitingNot applicable
Behavioral Weight Loss and Sleep Health Intervention
Updated 2026-09-03 · NCT07255287See eligibility →
Active, not recruitingNot applicable
BfedBwell INSPIRE Pilot
Updated 2026-09-03 · NCT07446595See eligibility →
Active, not recruitingNot applicable
4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity
Updated 2026-09-01 · NCT06399276See eligibility →
Active, not recruitingNot applicable
Timing Intervention of Morning Versus Evening Exercise
Updated 2026-07-30 · NCT05153252See eligibility →
Active, not recruitingNot applicable
Early vs. Late Time Restricted Eating vs. Daily Caloric Restriction
Updated 2026-03-24 · NCT05870982See eligibility →
Active, not recruitingNot applicable
Reprometabolic Syndrome Mediates Subfertility in Obesity
Updated 2026-03-02 · NCT02653092See eligibility →
Active, not recruitingNot applicable
Time and Nutrient-Dependent Effects of Aerobic Exercise on Metabolism in Adults (TANDEM Study)
Updated 2025-12-19 · NCT06311487See eligibility →
Active, not recruitingNot applicable
Dietary Reversal of the Reprometabolic Syndrome
Updated 2025-11-14 · NCT07227766See eligibility →
Active, not recruitingNot applicable
Daily Caloric Restriction in ADPKD
Updated 2025-08-12 · NCT04907799See eligibility →
Active, not recruitingNot applicable
Childhood Obesity Treatment Designed for Low Income and Hispanic Families
Updated 2025-03-30 · NCT05041855See eligibility →
Active, not recruitingPhase 1, Phase 2
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
Updated 2023-08-15 · NCT03584217See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.